Clinica Universidad de Navarra (CUN)

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, anaplastic astrocytoma, astrocytoma (excluding glioblastoma), epithelial neoplasm, follicular lymphoma, glioblastoma, glioma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor	Recruiting	Phase 1 / Phase 2	2026-09-22	NCT05765812
A Study to Evaluate INCB099280 in Participants With Advanced Cutaneous Squamous Cell Carcinoma	skin squamous cell carcinoma	Active, not recruiting	Phase 2	2026-08-17	NCT05888844
Clinical Trial of OMTX705 in Combination With Gemcitabine/Nab-Paclitaxel and Tislelizumab in Patients With Advanced/Metastatic Pancreatic Adenocarcinoma	Pancreatic Adenocarcinoma Metastatic	Recruiting	Phase 1	2026-01-29	NCT07377045

Clinical trials